Literature DB >> 32458851

High-altitude Tibetan fermented milk ameliorated cognitive dysfunction by modified gut microbiota in Alzheimer's disease transgenic mice.

JunLi Liu1, ChunYang Yu2, RunLe Li3, KunMei Liu2, GuoEn Jin3, RiLi Ge3, Feng Tang3, Sen Cui1.   

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative disease that is regarded as a growing global challenge. Accumulating evidence linking gut microbiota with AD has become intriguing. The purpose of this study was to investigate how Tibetan fermented milk affected memory impairment in amyloid precursor protein (APP)/presenilin-1 (PS1) mice, using APP/PS1 transgenic mice as examples. We used Tibetan fermented milk (the yogurt samples with the highest microbial diversity were selected by 16S sequencing) as an intervention in such mice for 20 weeks, with aseptic maintenance feed as their basic diet. At the end of the intervention, we collected fecal samples for 16S ribosomal ribonucleic acid (rRNA) sequencing. We evaluated the effects of Tibetan fermented milk on the mice's cognitive function by behavioral examination, and deposition of amyloid beta (Aβ) in the hippocampus and cortex of the mice by immunohistochemistry (IHC). Results showed that Tibetan fermented milk could improve cognitive impairment in APP/PS1 mice, including spatial learning/memory and object recognition/memory. Sequencing of 16S ribosomal RNA in mouse feces showed that Tibetan fermented milk increased intestinal microbial diversity and elevated the relative abundance of Bacteroides and Faecalibacterium spp. Mucispirillum and Ruminiclostridium were highly abundant in APP/PS1 mice. Additionally, correlation analysis revealed that cognitive function was correlated negatively with Mucispirillum abundance and positively with Muribaculum and Erysipelatoclostridium abundance. Tibetan fermented milk could also reduce deposition of Aβ in the cerebral cortex and hippocampus. Our data suggested that long-term intake of Tibetan fermented milk had a beneficial effect on the composition of intestinal flora, which was correlated with cognitive improvements in APP/PS1 mice and seemed to help prevent and treat AD-induced cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32458851     DOI: 10.1039/c9fo03007g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

Review 1.  Clinical and Preclinical Studies of Fermented Foods and Their Effects on Alzheimer's Disease.

Authors:  Muganti Rajah Kumar; Nor Farahin Azizi; Swee Keong Yeap; Janna Ong Abdullah; Melati Khalid; Abdul Rahman Omar; Mohd Azuraidi Osman; Adam Thean Chor Leow; Sharifah Alawieyah Syed Mortadza; Noorjahan Banu Alitheen
Journal:  Antioxidants (Basel)       Date:  2022-04-29

2.  Fecal Microbiota Transplantation Derived from Alzheimer's Disease Mice Worsens Brain Trauma Outcomes in Wild-Type Controls.

Authors:  Sirena Soriano; Kristen Curry; Qi Wang; Elsbeth Chow; Todd J Treangen; Sonia Villapol
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 3.  Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors.

Authors:  Wen Tang; Zhaoyou Meng; Ning Li; Yiyan Liu; Li Li; Dongfeng Chen; Yang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

4.  Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid.

Authors:  Ying Wu; Ze Ye; Pengya Feng; Rong Li; Xiao Chen; Xiaozhu Tian; Rong Han; Apurva Kakade; Pu Liu; Xiangkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  Probing gut-brain links in Alzheimer's disease with rifaximin.

Authors:  Paul V Suhocki; James S Ronald; Anna Mae E Diehl; David M Murdoch; P Murali Doraiswamy
Journal:  Alzheimers Dement (N Y)       Date:  2022-02-01

6.  Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome.

Authors:  Irina S Sadovnikova; Artem P Gureev; Daria A Ignatyeva; Maria V Gryaznova; Ekaterina V Chernyshova; Ekaterina P Krutskikh; Anastasia G Novikova; Vasily N Popov
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.